Neurologic Imaging

What Is the Best Imaging for Surveillance of a Previously Treated Cerebral Aneurysm?

·
What Is the Best Imaging for Surveillance of a Previously Treated Cerebral Aneurysm?

It’s a Tuesday afternoon in the neurosurgery clinic. You’re seeing a 58-year-old patient for their annual follow-up. Six years ago, they underwent successful endovascular coiling of a 6 mm anterior communicating artery aneurysm. They have been asymptomatic since, but the time has come for surveillance imaging to assess for coil compaction or aneurysm recurrence. The patient is asking if a “quick MRI” will suffice. You need to decide between non-invasive options like Magnetic Resonance Angiography (MRA) or Computed Tomography Angiography (CTA), and the invasive gold standard. This article outlines the American College of Radiology (ACR) guided workflow for this specific clinical decision. For surveillance of a previously treated cerebral aneurysm, Arteriography cervicocerebral is rated Usually appropriate, providing the highest diagnostic confidence.

Who Fits This Clinical Scenario for Aneurysm Surveillance?

This guidance applies specifically to asymptomatic patients with a known cerebral aneurysm that has already been treated via endovascular (coiling, stent-assisted coiling, flow diversion) or neurosurgical (clipping) methods. The imaging is being performed for routine, scheduled surveillance to monitor the stability of the treatment and the parent artery.

This workflow is not intended for several similar-sounding but distinct clinical situations:

  • Untreated Aneurysms: Patients with a known, unruptured aneurysm that is being monitored without intervention follow a different surveillance protocol.
  • Acute Symptoms: This guidance does not apply to patients presenting with new, acute neurologic symptoms (e.g., “worst headache of life,” cranial nerve palsy) suggestive of aneurysm rupture, growth, or subarachnoid hemorrhage (SAH). Those patients require an emergent workup.
  • Initial Screening: This is not the correct workflow for screening high-risk individuals (e.g., those with a strong family history or certain genetic conditions) who have not yet been diagnosed with a cerebral aneurysm.
  • Suspected Vasospasm: Patients with a recent SAH who are being monitored for cerebral vasospasm require a different imaging approach focused on vessel caliber and perfusion.

Correctly identifying the patient’s context—asymptomatic, previously treated, routine follow-up—is critical to selecting the most appropriate imaging study.

What Are You Looking for in Treated Aneurysm Surveillance?

Unlike a diagnostic workup for a new symptom, surveillance imaging is focused on a specific set of potential post-treatment changes. The goal is to detect complications before they become clinically significant. The primary findings you are assessing for include:

Aneurysm Recurrence or Regrowth: This is the most critical finding to identify. After endovascular coiling, the coil mass can compact over time, creating a space for blood to re-enter the aneurysm sac. After surgical clipping, a small portion of the aneurysm neck (a “remnant”) may have been left behind, which can regrow. The imaging study must be able to precisely delineate the interface between the treatment device (coils, clip) and the parent artery to detect any new or increased filling of the aneurysm.

Incomplete Occlusion: The initial treatment may not have achieved complete obliteration of the aneurysm. Surveillance imaging tracks whether this residual portion is stable, shrinking, or enlarging.

Parent Artery Integrity: The treatment itself can affect the parent vessel. For instance, a flow-diverting stent must remain patent to do its job. Surveillance imaging checks for in-stent stenosis, thrombosis, or unintended occlusion of adjacent branch vessels. Similarly, a surgical clip must not compromise or stenose the parent artery.

De Novo Aneurysm Formation: Patients with one aneurysm have a higher lifetime risk of developing new aneurysms elsewhere in the cerebral vasculature. While the primary goal is to monitor the treated lesion, surveillance studies provide an opportunity to survey the remaining vessels for any new developments.

Why Is Arteriography the Gold Standard for Treated Aneurysm Follow-Up?

The ACR designates four imaging modalities as Usually appropriate for this scenario, but they serve different roles. Digital Subtraction Angiography (DSA), or Arteriography cervicocerebral, remains the reference standard due to its superior spatial and temporal resolution.

Arteriography cervicocerebral provides a dynamic, real-time view of blood flow that is unparalleled for assessing the aneurysm neck and any potential recurrence. This is especially crucial when metallic hardware from coils, stents, or clips is present. These materials create significant artifacts on both CTA and MRA, which can obscure the precise area of interest—the aneurysm neck. DSA is less affected by these artifacts, allowing for a definitive assessment of occlusion. While it is an invasive procedure with a small risk of stroke and involves ionizing radiation (adult relative radiation level ☢☢☢), its diagnostic accuracy is the reason it is considered the gold standard for follow-up.

Other non-invasive options are also rated Usually appropriate and are often used as the primary surveillance method, with DSA reserved for indeterminate cases or high-risk lesions:

  • MRA head without IV contrast and MRA head without and with IV contrast: These are excellent non-invasive, radiation-free (adult RRL O) alternatives. Time-of-flight (TOF) MRA, in particular, is highly sensitive for detecting blood flow within a coiled aneurysm. However, susceptibility artifacts from the metallic coils can sometimes create signal voids that either mimic or obscure a small residual neck, making interpretation challenging.
  • CTA head with IV contrast: This study is fast and widely available. Modern techniques can help mitigate some of the beam-hardening artifacts from clips and coils. However, it still involves both iodinated contrast and ionizing radiation (adult RRL ☢☢☢), and artifact can still limit the evaluation of the aneurysm neck, particularly with densely packed coils.

Why are other studies rated lower?

  • MRI head without IV contrast (Usually not appropriate): A standard, non-angiographic MRI of the brain is not designed to evaluate blood vessels with the detail required. It cannot assess flow dynamics or the completeness of aneurysm occlusion and is therefore insufficient for this purpose.
  • US duplex Doppler transcranial (Usually not appropriate): While transcranial Doppler is useful for monitoring for vasospasm after an acute SAH, it lacks the spatial resolution to visualize the morphology of a treated aneurysm or detect subtle recurrence at the neck.

The choice between DSA, MRA, and CTA often depends on the type of initial treatment (clips are more challenging for MRA, dense coils for CTA), institutional preference, and the pre-test probability of a complex recurrence.

What’s Next After Imaging? Downstream Workflow

The results of surveillance imaging will guide the subsequent clinical management, which typically falls into one of three pathways:

  • Result: Stable and Complete Occlusion. If the study confirms that the aneurysm remains completely obliterated with no evidence of recurrence and the parent vessel is patent, the patient can continue routine follow-up. The interval for the next imaging study may be lengthened based on the time since treatment and the specific characteristics of the aneurysm.
  • Result: Small, Stable Remnant/Recurrence. If a small, stable residual neck or minor coil compaction is identified, the patient may continue close surveillance. The imaging interval is often shortened (e.g., from annually to every 6 months) to monitor for any progression. A switch to a higher-resolution modality, such as from MRA to DSA, may be warranted to better characterize the finding.
  • Result: Significant Recurrence or New Finding. If imaging demonstrates significant aneurysm regrowth, new filling of the sac, or compromise of the parent artery (e.g., in-stent stenosis), this triggers a clinical re-evaluation for retreatment. The patient should be referred back to their treating neurosurgeon or neurointerventional radiologist to discuss options, which may include further coiling, flow diversion, or open surgery. This finding essentially moves the patient from a “surveillance” scenario to a “planning for treatment” scenario.

Pitfalls to Avoid (and When to Get Help)

  • Artifact Misinterpretation: The most common pitfall is misinterpreting metallic artifact on MRA or CTA as either aneurysm recurrence (false positive) or complete occlusion (false negative). Always compare with prior studies.
  • Choosing the Wrong Modality for the Hardware: Ordering an MRA for a patient with a type of surgical clip not certified as MR-safe is a critical safety error. For coiled aneurysms, be aware that MRA may be less reliable than CTA or DSA.
  • Inconsistent Follow-up Intervals: Adherence to a consistent, risk-stratified surveillance schedule is key. Allowing long gaps in follow-up can lead to a treatable recurrence being missed until it becomes a major problem.
  • Ignoring the Rest of the Vasculature: While focused on the treated site, remember to scrutinize the remainder of the cerebral arteries for any de novo aneurysms that may have formed since the last scan.

If a non-invasive study (MRA or CTA) shows an indeterminate or concerning finding, escalate by obtaining a formal Arteriography (DSA) for definitive characterization and consulting with the treating neurovascular specialist.

Related ACR Topics and Tools

For a comprehensive overview of all clinical variants related to cerebrovascular disease, please consult the parent topic guide. The resources below can assist in navigating adjacent scenarios, understanding imaging techniques, and discussing radiation safety with patients.

Frequently Asked Questions

How often should a treated cerebral aneurysm be monitored with imaging?

The frequency of surveillance imaging depends on several factors, including the type of treatment (coiling vs. clipping), the initial completeness of occlusion, the size and location of the aneurysm, and the time elapsed since treatment. A common protocol might involve imaging at 6 months, 1 year, 3 years, and 5 years post-treatment, but this should be individualized by the treating neurovascular specialist.

Is MRA a good enough substitute for DSA in all surveillance cases?

While MRA is rated ‘Usually appropriate’ and is an excellent non-invasive tool, it is not a perfect substitute in all cases. Metallic artifact from coils can limit its accuracy. For aneurysms with complex anatomy, wide necks, or indeterminate findings on MRA, Digital Subtraction Angiography (DSA) is often necessary for a definitive assessment.

What is the main difference in surveillance for a clipped versus a coiled aneurysm?

Surgically clipped aneurysms are generally considered more durable, with lower recurrence rates than coiled aneurysms. Therefore, surveillance imaging may be less frequent. However, CTA and DSA are often preferred over MRA for clipped aneurysms due to the significant metallic artifact generated by the clip on MRI sequences.

Does the patient need contrast for a surveillance MRA of a treated aneurysm?

The ACR rates both ‘MRA head without IV contrast’ and ‘MRA head without and with IV contrast’ as ‘Usually appropriate.’ Time-of-flight (TOF) MRA, performed without contrast, is the primary sequence for detecting flow. Contrast-enhanced MRA can sometimes be helpful to define the vessel anatomy, but it is not always required and depends on institutional protocol and the specific clinical question.

If a small recurrence is found, does the patient always need another procedure?

Not necessarily. A small, stable recurrence or residual filling, especially if it does not enlarge over time, may be managed with continued close surveillance. The decision to retreat is complex and depends on the size and morphology of the recurrence, the patient’s age and comorbidities, and the risks of another intervention. This decision is always made in consultation with a neurovascular team.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026